Paul N. Saleh's most recent trade in Anterix Inc was a trade of 5,209 Common Stock done . Disclosure was reported to the exchange on Aug. 28, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anterix Inc | Paul N. Saleh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2023 | 5,209 | 24,175 (0%) | 0% | 0 | Common Stock | |
| Anterix Inc | Paul N. Saleh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2022 | 3,595 | 18,966 (0%) | 0% | 0 | Common Stock | |
| Anterix Inc | Paul N. Saleh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 2,834 | 15,371 (0%) | 0% | 0 | Common Stock | |
| DXC Technology Co | Paul N. Saleh | EVP & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 44,148 | 417,784 (0%) | 0% | 0 | Common Stock | |
| DXC Technology Co | Paul N. Saleh | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.36 per share. | 01 Oct 2020 | 6,637 | 411,147 (0%) | 0% | 18.4 | 121,855 | Common Stock |
| Anterix Inc | Paul N. Saleh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Sep 2020 | 2,072 | 12,537 (0%) | 0% | 0 | Common Stock |